On linezolid efficacy and tolerabilityDE LORENZO, S; CENTIS, R; D'AMBROSIO, L et al.The European respiratory journal. 2012, Vol 39, Num 3, pp 770-772, issn 0903-1936, 3 p.Article

Le linézolide, premier antibiotique de la famille des oxazolidinones = Linezolid, the first oxazolidinone antibioticDUTRONC, H; BOCQUENTIN, F; GALPERINE, T et al.Médecine et maladies infectieuses. 2005, Vol 35, Num 9, pp 427-434, issn 0399-077X, 8 p.Article

LinezolidNARANG, Manish; GOMBER, Sunil.Indian pediatrics. 2004, Vol 41, Num 11, pp 1129-1132, issn 0019-6061, 4 p.Article

An update on the oxazolidinone antibioticsABDEL-RAHMAN, S. M; KEARNS, G. L.The Pediatric infectious disease journal. 1999, Vol 18, Num 12, pp 1101-1102, issn 0891-3668Conference Paper

Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalisMARRA, Alexandre R; MAJOR, Yvette; EDMOND, Michael B et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 5, pp 1915-1916, issn 0095-1137, 2 p.Article

Population pharmacokinetics of linezolid in patients treated in a compassionate-use programMEAGHER, Alison K; FORREST, Alan; RAYNER, Craig R et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 2, pp 548-553, issn 0066-4804, 6 p.Article

Apport du linézolide dans le traitement des infections compliquées de la peau et des tissus mous = Contribution of linezolid to the treatment of complicated infections of the skin and soft tissuesGAUZIT, Rémy.La Presse médicale (1983). 2003, Vol 32, Num 13, pp 1S17-1S20, issn 0755-4982, CAH2Conference Paper

Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedingsBERINGER, Paul; NGUYEN, Megan; HOEM, Nils et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3676-3681, issn 0066-4804, 6 p.Article

Linezolid treatment of ventriculoperitoneal shunt infection without implant removalCASTRO, P; SORIANO, A; ESCRICH, C et al.European journal of clinical microbiology & infectious diseases (Print). 2005, Vol 24, Num 9, pp 603-606, issn 0934-9723, 4 p.Article

Linezolid use associated with lactic acidosisKOPTERIDES, Petros; PAPADOMICHELAKIS, Evangelos; ARMAGANIDIS, Apostolos et al.Scandinavian journal of infectious diseases. 2005, Vol 37, Num 2, pp 153-154, issn 0036-5548, 2 p.Article

Oxazolidinones: activity, mode of action, and mechanism of resistanceBOZDOGAN, Bülent; APPELBAUM, Peter C.International journal of antimicrobial agents. 2004, Vol 23, Num 2, pp 113-119, issn 0924-8579, 7 p.Article

Use of linezolid in childrenKAPLAN, Sheldon L.The Pediatric infectious disease journal. 2003, Vol 22, Num 9, issn 0891-3668, 52 p., SUPSerial Issue

Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cellsCHAMPNEY, W. Scott; MILLER, Mindy.Current microbiology (Print). 2002, Vol 44, Num 5, pp 350-356, issn 0343-8651Article

Linezolid-induced anemia and thrombocytopeniaWALDREP, Travis W; SKIEST, Daniel J.Pharmacotherapy. 2002, Vol 22, Num 1, pp 109-112, issn 0277-0008Article

Thrombocytopenia associated with linezolid therapyATTASSI, Kinan; HERSHBERGER, Ellie; ALAM, Rabiul et al.Clinical infectious diseases. 2002, Vol 34, Num 5, pp 695-698, issn 1058-4838Article

Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomesWYNALDA, M. A; HAUER, M. J; WIENKERS, L. C et al.Drug metabolism and disposition. 2000, Vol 28, Num 9, pp 1014-1017, issn 0090-9556Article

Linezolid -associated toxic optic neuropathyRUCKER, J. C; HAMILTON, S. R; BARDENSTEIN, D et al.Neurology. 2006, Vol 66, Num 4, pp 595-598, issn 0028-3878, 4 p.Article

Aqueous and vitreous penetration of linezolid (Zyvox) after oral administrationFISCELLA, Richard G; LAI, Wico W; BUERK, Bruce et al.Ophthalmology (Rochester, MN). 2004, Vol 111, Num 6, pp 1191-1195, issn 0161-6420, 5 p.Article

Linezolid therapy for orthopedic InfectionsRAZONABLE, Raymund R; OSMON, Douglas R; STECKELBERG, James M et al.Mayo Clinic proceedings. 2004, Vol 79, Num 9, pp 1137-1144, issn 0025-6196, 8 p.Article

Clinical experience with linezolid in the treatment of resistant Gram-positive infectionsANTONY, Suresh J; DIAZ-VASQUEZ, Emma; STRATTON, Charles et al.Journal of the National Medical Association. 2001, Vol 93, Num 10, pp 386-391, issn 0027-9684Article

High-resolution melting analysis for rapid detection of linezolid resistance (mediated by G2576T mutation) in Staphylococcus epidermidisGABRIEL, Emma M; DOUARRE, Pierre E; FITZGIBBON, Siobhan et al.Journal of microbiological methods. 2012, Vol 90, Num 2, pp 134-136, issn 0167-7012, 3 p.Article

The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococciSCHEETZ, Marc H; CHAO QI; NOSKIN, Gary A et al.Diagnostic microbiology and infectious disease. 2006, Vol 56, Num 4, pp 407-413, issn 0732-8893, 7 p.Article

Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitisSTEIN, Gary E; SCHOOLEY, Sharon L; PELOQUIN, Charles A et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 3, pp 427-432, issn 1060-0280, 6 p.Article

Appropriate antibiotic use and why it is important: the challenges of bacterial resistanceLIEBERMAN, Jay M.The Pediatric infectious disease journal. 2003, Vol 22, Num 12, pp 1143-1151, issn 0891-3668, 9 p.Conference Paper

Linezolid: a review of safety and tolerabilityVINH, Donald C; RUBINSTEIN, Ethan.The Journal of infection. 2009, Vol 59, issn 0163-4453, S59-S74, SUP1Article